Connect Biopharma Holdings Limited (CNTB) Social Stream
CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Price Targets From Analysts
Use the tables below to see what analysts covering CONNECT BIOPHARMA HOLDINGS LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-18 | 3 | $32 | $27 | $30 | $1.05 | 2757.14% |
| 2022-04-08 | 3 | $25 | $19 | $22 | $1.05 | 1995.24% |
| 2022-05-04 | 3 | $13 | $1.5 | $7.833 | $1.05 | 646% |
| 2022-06-06 | 4 | $13 | $1.5 | $7.125 | $1.05 | 578.57% |
| 2022-09-15 | 4 | $9 | $1.75 | $5.687 | $1.05 | 441.62% |
| 2023-02-08 | 4 | $7 | $1.75 | $5.187 | $1.05 | 394% |
| 2023-04-12 | 3 | $7 | $1.75 | $5.187 | $1.05 | 394% |
| 2023-07-11 | 2 | $7 | $5 | $6.333 | $1.05 | 503.14% |
| 2023-09-12 | 1 | $7 | $7 | $7 | $1.05 | 566.67% |
| 2023-09-13 | 2 | $7 | $5 | $6 | $1.05 | 471.43% |
The Trend in the Analyst Price Target
CNTB's average price target has moved down $16 over the prior 17 months.
CNTB reports an average of 480.32% for its upside potential over the past 31 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 4 | 7 | 1.75 | 5.187 | 1.17 | 343.33% |
| 2023-04-12 | 2 | 7 | 1.75 | 5.187 | 1.12 | 363.12% |
| 2023-04-12 | 3 | 7 | 5.00 | 6.333 | 1.12 | 465.45% |
| 2023-04-12 | 3 | 7 | 1.75 | 5.187 | 1.12 | 363.12% |
| 2023-09-13 | 2 | 7 | 5.00 | 6.000 | 0.78 | 669.23% |
CNTB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
CNTB's average broker recommendation rating improved by 0.5 over the prior 52 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNTB as an investment opportunity.
- In terms of how CONNECT BIOPHARMA HOLDINGS LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1032.5% of that group.
- CONNECT BIOPHARMA HOLDINGS LTD's number of analysts covering the stock is higher than 79.55% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, CONNECT BIOPHARMA HOLDINGS LTD's average analyst price target is higher than 114.11% of them.
- In the context of Healthcare stocks, CONNECT BIOPHARMA HOLDINGS LTD's variance in analysts' estimates is lower than -479.17% of them.
In the Pharmaceutical Products industry, LVTX, EWTX, and DSGN are the three stocks most similar to CONNECT BIOPHARMA HOLDINGS LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CNTB using the data that counts. Try POWR Ratings for free.